TBPH Q1 2017 Earnings — Theravance Biopharma, Inc. Revenue & Financial Results | Market Cap Arena

TBPHTheravance Biopharma, Inc.

$697M

Q1 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$3M-83.2% YoY

Gross Profit

$3M81.7% margin

Operating Income

-$59M-1905.7% margin

Net Income

-$65M-2115.9% margin

EPS (Diluted)

$-1.27

QoQ Revenue Growth

-45.8%

Cash Flow

Operating Cash Flow

-$50M

Free Cash Flow

-$51M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$588M

Total Liabilities

$294M

Stockholders' Equity

$294M

Cash & Equivalents

$170M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$18M	-83.2%
Gross Profit	$3M	$18M	-85.7%
Operating Income	-$59M	-$42M	-41.3%
Net Income	-$65M	-$42M	-55.0%